Griffin Asset Management
PLSE icon

Griffin Asset Management’s Pulse Biosciences PLSE Stock Holding History

Griffin Asset Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.2M Sell
144,211
-83,074
-37% -$3.5M 0.77% 38
2026
Q2 		$6.3M Buy
227,285
+2,108
+0.9% +$49.7K 0.66% 48
2026
Q1 		$4.86M Sell
225,177
-1,135
-0.5% -$21K 0.55% 52
2025
Q4 		$3.11M Sell
226,312
-1,000
-0.4% -$15.6K 0.34% 76
2025
Q3 		$4.02M Sell
227,312
-2,347
-1% -$37.1K 0.45% 60
2025
Q2 		$3.47M Sell
229,659
-3,898
-2% -$64.7K 0.41% 70
2025
Q1 		$3.76M Sell
233,557
-3,990
-2% -$74.4K 0.46% 62
2024
Q4 		$4.14M Sell
237,547
-19,902
-8% -$351K 0.49% 56
2024
Q3 		$4.52M Sell
257,449
-230
-0.1% -$3.92K 0.51% 53
2024
Q2 		$2.88M Sell
257,679
-42,641
-14% -$402K 0.33% 71
2024
Q1 		$2.62M Buy
300,320
+40,700
+16% +$374K 0.31% 76
2023
Q4 		$3.18M Sell
259,620
-15,140
-6% -$105K 0.4% 67
2023
Q3 		$1.11M Buy
274,760
+80,410
+41% +$500K 0.16% 120
2023
Q2 		$1.4M Buy
194,350
+25,000
+15% +$160K 0.19% 111
2023
Q1 		$569K Sell
169,350
-6,543
-4% -$19.7K 0.08% 161
2022
Q4 		$487K Buy
175,893
+90,059
+105% +$202K 0.07% 160
2022
Q3 		$197K Buy
85,834
+17,383
+25% +$28.2K 0.03% 198
2022
Q2 		$105K Sell
68,451
-6,400
-9% -$16.1K 0.02% 207
2022
Q1 		$364K Sell
74,851
-1,108
-1% -$9.07K 0.05% 181
2021
Q4 		$1.12M Buy
75,959
+14,488
+24% +$289K 0.14% 134
2021
Q3 		$1.33M Buy
61,471
+3,000
+5% +$64.5K 0.17% 123
2021
Q2 		$959K Hold
58,471
– – 0.12% 146
2021
Q1 		$1.38M Sell
58,471
-28,308
-33% -$846K 0.18% 117
2020
Q4 		$2.07M Buy
86,779
+18,503
+27% +$294K 0.27% 81
2020
Q3 		$805K Buy
68,276
+26,452
+63% +$285K 0.12% 128
2020
Q2 		$437K Sell
41,824
-1,196
-3% -$10.8K 0.07% 156
2020
Q1 		$308K Sell
43,020
-6,765
-14% -$70.2K 0.06% 164
2019
Q4 		$668K Buy
49,785
+1,750
+4% +$24.9K 0.09% 143
2019
Q3 		$742K Sell
48,035
-9,280
-16% -$121K 0.12% 135
2019
Q2 		$757K Buy
57,315
+5,955
+12% +$81.2K 0.1% 162
2019
Q1 		$903K Buy
+51,360
New +$806K 0.13% 150

Other funds holding PLSE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Westside Investment Management
Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Griffin Asset Management's PLSE Position: Q3 2026 in Review

Griffin Asset Management reduced its Pulse Biosciences (PLSE) stake by 37% in Q3 2026, selling an estimated $3.5M and leaving 144,211 shares worth $7.2M. The position accounts for 0.77% of the portfolio, ranked #38.

Griffin Asset Management first reported a position in PLSE in Q1 2019 and has held it in 31 quarters since. 47 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

  • Griffin Asset Management held 144,211 shares of Pulse Biosciences worth $7.2M as of Q3 2026.
  • Griffin Asset Management sold 83,074 Pulse Biosciences shares in Q3 2026, an estimated $3.5M.
  • Pulse Biosciences made up 0.77% of Griffin Asset Management's portfolio in Q3 2026, its #38 holding.
  • Griffin Asset Management first reported a position in Pulse Biosciences in Q1 2019 and has held it in 31 quarters since.
  • 47 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on Griffin Asset Management's 13F filing for Q3 2026, filed 22 Oct 2026.